PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions.

EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares – Biotech Investments

Siegfried AG / Key word(s): Bond 14-Jun-2024 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

June 15, 2024

Opinion | An Analysis of the Blizzard of Lawsuits to Block Drug-Price Negotiations

Gostin is a leading figure in national and global health law. Twinamatsiko and Baron are experts in health law and policy. Prescription drug prices in

August 10, 2023

J&J touts success of Vyvgart competitor in two autoimmune disease trials, including key myasthenia gravis study

Johnson & Johnson’s experimental antibody nipocalimab reduced the severity of symptoms related to two autoimmune conditions — first in a pivotal study for generalized myasthenia

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.